Living with severe aortic stenosis means dealing with a narrowed heart valve that makes it harder for blood to flow. Doctors often have to choose between two main treatments: surgery (SAVR) or a less invasive procedure called TAVR, which uses a balloon-expandable SAPIEN 3 valve. A major question for patients is whether the size of their heart's opening, known as the annulus, changes which treatment is safer.
A follow-up analysis of a large study involving 925 low-risk patients looked at these outcomes over about five years. The results showed that both TAVR and surgery had similar rates of death, stroke, or rehospitalization. Importantly, the size of the patient's annulus did not change the outcome; both groups performed similarly regardless of their specific anatomy.
Other measures, like valve failure and overall health status at five years, were also similar between the two methods. While this was a post hoc analysis, meaning it looked back at existing data from a previous trial, it suggests that TAVR is a reliable option for these patients. You should talk to your doctor to see which path fits your specific needs.
